Clinical Trial: Prenatal Examination of Deletion 22q11 Syndrome : Thymic Dysgenesis THYMI Study

Study Status: Enrolling by invitation
Recruit Status: Enrolling by invitation
Study Type: Observational

Official Title: Research of Thymix Dysgenesis in Prenatal Examination of Deletion 22q11 Syndrome

Brief Summary: 22q11.2 microdeletion seems the prenatally under-diagnosed . Indeed , there is a mismatch between the series on the heart rate of 22q11.2 antenatal 84% against 30% in the adult series despite a perinatal mortality of 16% suggesting opportunities for improvement in the prenatal diagnosis of fetus with a microdeletion 22q11.2 , especially without heart disease

Detailed Summary:
Sponsor: Centre Hospitalier Universitaire de Nīmes

Current Primary Outcome: Thymic thoracic ratio " measurement on sonographic picture of the fetal 3 vessels slides will be done by independent investigator. [ Time Frame: day 0 ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Centre Hospitalier Universitaire de Nīmes

Dates:
Date Received: August 26, 2016
Date Started: October 2016
Date Completion: July 2017
Last Updated: August 31, 2016
Last Verified: August 2016